<link rel="stylesheet" href="styles.f3b1fba60ec7970c.css">

Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy (vol 23, 136, 2023)

dc.contributor.authorKaracin, Cengiz
dc.contributor.authorÖksüzoğlu, Berna
dc.contributor.authorDemirci, Ayşe
dc.contributor.authorKeskinkılıç, Merve
dc.contributor.authorKöse Baytemur, Naziyet
dc.contributor.authorYılmaz, Funda
dc.contributor.authorSelvi, Oğuzhan
dc.contributor.authorHacıbekiroğlu, İlhan
dc.date.accessioned2023-03-27T07:48:47Z
dc.date.available2023-03-27T07:48:47Z
dc.date.issued2023
dc.departmentİstanbul Medipol Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, İç Hastalıkları Ana Bilim Dalı
dc.description.abstractFollowing publication of the original article [1], the authors reported an error in the author name of Enes Erul.
dc.identifier.citationKaracin, C., Öksüzoğlu, B., Demirci, A., Keskinkılıç, M., Köse Baytemur, N., Yılmaz, F. ... Hacıbekiroğlu, İ. (2023). Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy (vol 23, 136, 2023). BMC Cancer, 23(1). https://dx.doi.org/10.1186/s12885-023-10662-3
dc.identifier.doi10.1186/s12885-023-10662-3
dc.identifier.issn1471-2407
dc.identifier.issue1
dc.identifier.pmid36849943
dc.identifier.scopus2-s2.0-85148970683
dc.identifier.scopusqualityQ2
dc.identifier.urihttps://dx.doi.org/10.1186/s12885-023-10662-3
dc.identifier.urihttps://hdl.handle.net/20.500.12511/10700
dc.identifier.volume23
dc.identifier.wos000941147400001en_US
dc.identifier.wosqualityQ2
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.institutionauthorSakin, Abdullah
dc.language.isoen
dc.publisherBMC
dc.relation.ispartofBMC Canceren_US
dc.relation.publicationcategoryDiğer
dc.rightsAttribution 4.0 International*
dc.rightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/*
dc.subjectCDK 4/6 Inhibitor Therapy
dc.subjectBreast Cancer
dc.subjectDisease Progression
dc.titleEfficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy (vol 23, 136, 2023)
dc.title.alternativeCorrection: Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy (BMC Cancer, (2023), 23, 1, (136), 10.1186/s12885-023-10609-8)
dc.typeOther

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Sakin-Abdullah-2023.pdf
Size:
684.12 KB
Format:
Adobe Portable Document Format
Description:
Tam Metin / Full Text

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.44 KB
Format:
Item-specific license agreed upon to submission
Description: